35 1.5.1. Les effets secondaires 35 1.5.1.1. Les troubles gastro-intestinaux, p.36 ,
Les rétentions trophoblastiques et grossesses arrêtées non évacuées, p.37 ,
62 jours avec un écart-type=4,15. Figure 31: Durée des douleurs Les saignements : Ils durent en moyenne 10,45 jours avec un écart-type = 4,48, Le minimum est de 2 jours et le maximum relevé de 21 jours ,
Ils sont présents chez 41 ,
Medical abortion in lactating women ??? low levels of mifepristone in breast milk, Acta Obstetricia et Gynecologica Scandinavica, vol.89, issue.5, pp.618-640, 2010. ,
DOI : 10.3109/00016341003721037
Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol, N Engl J Med Mai, vol.27328, pp.1509-1513, 1993. ,
"Safety, Efficacy, and Acceptability of Medical Abortion in China, Cuba, and India: A Comparative Trial of Mifepristone-Misoprostol versus Surgical Abortion.", Studies in Family Planning, vol.28, issue.2, pp.431-438, 1997. ,
DOI : 10.2307/2138124
Early pregnancy termination with mifepristone and misoprostol in the United States, N Engl J Med Avril, vol.30338, pp.1241-1248, 1998. ,
A randomized comparison of mifepristone and self-administered oral or vaginal misoprostol for early abortion, The European Journal of Contraception & Reproductive Health Care, vol.312, issue.3, pp.171-177, 2000. ,
DOI : 10.1016/S0029-7844(98)00436-0
Medical methods for first trimester abortion, Cochrane Database Syst Rev Online, issue.2, p.2855, 2004. ,
Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy, Contraception, vol.80, issue.1, pp.95-100, 2009. ,
DOI : 10.1016/j.contraception.2009.01.011
Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation, Human Reproduction, vol.16, issue.10, pp.2098-102, 2001. ,
DOI : 10.1093/humrep/16.10.2098
Comparaison of gemeprost and vaginal misoprostol in first trimester mifepristone-induced abortion. Contraception, pp.28-32, 2005. ,
Pharmacologie du misoprostol (donn??es pharmacocin??tiques, tol??rance et effets t??ratog??nes), Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.43, issue.2, pp.114-136, 2014. ,
DOI : 10.1016/j.jgyn.2013.11.006
Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol, Hum Reprod, pp.1912-1920, 2007. ,
Pharmacokinetics of different routes of administration of Misoprostol. Hum Reprod Research Group on Postovulatory Methods of Fertility Regulation. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled non inferiority trial, FebBJOG, vol.17117, issue.210, pp.332-336, 2002. ,
First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review, Contraception, vol.87, issue.1, pp.26-37, 2013. ,
DOI : 10.1016/j.contraception.2012.06.011
A randomized clinical trial comparing the short-term sideeffects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63 days' gestation. Contraception, pp.480-485, 2013. ,
Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy, Contraception, vol.66, issue.4, pp.247-50, 2002. ,
DOI : 10.1016/S0010-7824(02)00366-9
Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol, Contraception, vol.79, issue.2, pp.84-90, 2009. ,
DOI : 10.1016/j.contraception.2008.09.001
Two Distinct Oral Routes of Misoprostol in Mifepristone Medical Abortion, Obstetrics & Gynecology, vol.112, issue.6, pp.1303-1313, 2008. ,
DOI : 10.1097/AOG.0b013e31818d8eb4
Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days, Contraception, vol.80, issue.3, pp.282-288, 2009. ,
DOI : 10.1016/j.contraception.2009.03.010
A pilot study of mifepristone in combinationwith sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation, Contraception, 2003. ,
Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period, Contraception, vol.72, issue.5, pp.328-360, 2005. ,
DOI : 10.1016/j.contraception.2005.05.017
Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days, Human Reproduction, vol.25, issue.5, pp.1153-1157, 2010. ,
DOI : 10.1093/humrep/deq037
A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion. Contraception, pp.251-257, 2012. ,
Early medical abortion using low-dose mifepristone followed by buccal misoprostol: a large Australian observational study, The Medical Journal of Australia, vol.197, issue.5 ,
DOI : 10.5694/mja12.10297
Are two doses of misoprostol after mifepristone for early abortion better than one?, BJOG: An International Journal of Obstetrics & Gynaecology, vol.284, issue.3, pp.271-279, 2007. ,
DOI : 10.1111/j.1471-0528.2006.01208.x
Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac, Contraception, vol.78, issue.4, pp.332-335, 2008. ,
DOI : 10.1016/j.contraception.2008.06.002
Pharmacokinetics of repeated doses of misoprostol, Human Reproduction, vol.24, issue.8, pp.1862-1869, 2009. ,
DOI : 10.1093/humrep/dep108
Evidence for shortening the time interval of prostaglandin after mifepristone for medical abortion, Contraception, vol.74, issue.1, pp.42-46, 2006. ,
DOI : 10.1016/j.contraception.2006.03.014
Flexible mifepristone and misoprostol administration interval for first-trimester medical termination. Contraception, 2010. ,
Medical abortion with mifepristone and home administration of misoprostol up to 63??days' gestation, Acta Obstetricia et Gynecologica Scandinavica, vol.119, issue.2 Pt 1, pp.647-53 ,
DOI : 10.1111/aogs.12398
Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: a systematic review. Bull World Health Organ, pp.360-370, 2011. ,
Pain control in first-trimester and second-trimester medical termination of pregnancy: a systematic review, Contraception, vol.83, issue.2, pp.116-142, 2011. ,
DOI : 10.1016/j.contraception.2010.07.014
Ibuprofen and paracetamol for pain relief during medical abortion: a double-blind randomized controlled study, Fertility and Sterility, vol.91, issue.5, pp.1877-80, 2009. ,
DOI : 10.1016/j.fertnstert.2008.01.084
Pain during medical abortion: predicting factors from gynecologic history and medical staff evaluation of severity, Contraception, vol.83, issue.4, pp.357-361, 2011. ,
DOI : 10.1016/j.contraception.2010.08.006
after Medical Abortion, New England Journal of Medicine, vol.353, issue.22, pp.2352-60, 2005. ,
DOI : 10.1056/NEJMoa051620
Mifepristone-induced abortion and vaginal bleeding in subsequentpregnancy, Contraception, 2011. ,
Is induced abortion with misoprostol a risk factor for late abortion or preterm delivery in subsequent pregnancies?, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.145, issue.1, pp.53-59, 2009. ,
DOI : 10.1016/j.ejogrb.2009.04.028
Induced First-Trimester Abortion and Risk of Mental Disorder, New England Journal of Medicine, vol.364, issue.4, 2011. ,
DOI : 10.1056/NEJMoa0905882
Abortion and mental health: Evaluating the evidence., American Psychologist, vol.64, issue.9, 2009. ,
DOI : 10.1037/a0017497
Analysis of failure in medical abortion, Contraception, vol.54, issue.6, pp.323-330, 1996. ,
DOI : 10.1016/S0010-7824(96)00206-5
Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment, Contraception, pp.402-409, 2012. ,
Observance de la consultation post-IVG médicamenteuse dans la métropole Nice Côte d'Azur : enquête de 3 mois auprès de 160 patientes [Thèse d'exercice, 2013. ,
Outcome of medical abortion through 63 days in women with prior cesarean section, Contraception, vol.76, issue.2, p.163, 2007. ,
DOI : 10.1016/j.contraception.2007.05.023
Facteurs cliniques et échographiques influençant le succès du misoprostol pour grossesse arrêtée au premier trimestre. Gynécologie Obstétrique & Fertilité, Feb, vol.40, issue.2, pp.84-87, 2012. ,
Effect of Previous Live Birth and Prior Route of Delivery on the Outcome of Early Medical Abortion, Obstetrics & Gynecology, vol.113, issue.3, 2009. ,
DOI : 10.1097/AOG.0b013e31819638e6
Risk factors for unsuccessful medical abortion with mifepristone and misoprostol, Acta Obstetricia et Gynecologica Scandinavica, vol.86, issue.4, pp.462-466, 2007. ,
DOI : 10.1080/00016340701203632
Évaluation de l'efficacité de l'IVG médicamenteuse en Ariège et recherche des principaux facteurs d'échecs ,
Facteurs d'échec de l'interruption volontaire de grossesse réalisée par méthode médicamenteuse jusqu'à 9 semaines d'aménorrhée dans un centre d'orthogénie de l ,
Facteurs de risque d'échec de la méthode médicamenteuse d'interruption volontaire de grossesse jusqu'à 49 jours d'aménorrhée [Thèse d'exercice : Médecine Générale], 2008. ,
Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases, BJOG: An International Journal of Obstetrics and Gynaecology, vol.99, issue.2, 2002. ,
DOI : 10.1016/S0010-7824(00)00090-1
Management of side effects and complications in medical abortion American Journal of Obstetric and gynecology, pp.65-75, 2000. ,
Interruption Volontaire de Grossesse médicamenteuse, 2011. ,
Rates of Serious Infection after Changes in Regimens for Medical Abortion, New England Journal of Medicine, vol.361, issue.2, pp.145-151, 2009. ,
DOI : 10.1056/NEJMoa0809146
Efficacit?? et acceptabilit?? de l'interruption volontaire de grossesse par m??thode m??dicamenteuse pratiqu??e sans hospitalisation dans le cadre d'un r??seau ville???h??pital??: ??tude prospective sur 433 patientes, Gyn??cologie Obst??trique & Fertilit??, vol.33, issue.4 ,
DOI : 10.1016/j.gyobfe.2005.02.021
Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countries, BMC Pregnancy and Childbirth, vol.113, issue.4, p.127, 2012. ,
DOI : 10.1097/AOG.0b013e31819930f9
Evaluation de l'efficacité et des facteurs de risque d'échecs des IVG médicamenteuses à partir d'une description de 4153 cas [Thèse d'exercice : Médecine Générale], 2010. ,